On Monday, Sage Therapeutics Inc (NASDAQ: SAGE) was -3.30% down from the session before settling in for the closing price of $13.33. A 52-week range
Witnessing the stock’s movement on the chart, on Wednesday, Sage Therapeutics Inc (NASDAQ: SAGE) had a quiet start as it plunged -19.58% to $12.57, before
Sage Therapeutics Inc (NASDAQ: SAGE) on Friday, plunged -6.82% from the previous trading day, before settling in for the closing price of $16.57. Within the
Sage Therapeutics Inc (NASDAQ: SAGE) on Tuesday, plunged -0.48% from the previous trading day ,before settling in for the closing price of $16.60. Within the
As on Thursday, Sage Therapeutics Inc (NASDAQ: SAGE) started slowly as it slid -3.32% to $16.58, before settling in for the price of $17.15 at
On Monday, Sage Therapeutics Inc (NASDAQ: SAGE) was -4.48% down from the session before settling in for the closing price of $18.74. A 52-week range
Sage Therapeutics Inc (NASDAQ: SAGE) on Tuesday, plunged -0.37% from the previous trading day, before settling in for the closing price of $18.69. Within the
During the past 52 weeks, Sage Therapeutics (SAGE) shares have fallen about 25%. Another reason for the decline in quotations is the drug’s inability to
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
